Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
6.69
-0.09 (-1.33%)
At close: Nov 6, 2025, 4:00 PM EST
6.69
0.00 (0.00%)
After-hours: Nov 6, 2025, 7:00 PM EST
Bausch Health Companies Revenue
Bausch Health Companies had revenue of $2.68B in the quarter ending September 30, 2025, with 6.81% growth. This brings the company's revenue in the last twelve months to $10.03B, up 5.86% year-over-year. In the year 2024, Bausch Health Companies had annual revenue of $9.63B with 9.91% growth.
Revenue (ttm)
$10.03B
Revenue Growth
+5.86%
P/S Ratio
0.25
Revenue / Employee
$484,493
Employees
20,700
Market Cap
2.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.63B | 868.00M | 9.91% |
| Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
| Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
| Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
| Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
BHC News
- 1 day ago - Bausch Health's OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease - Accesswire
- 3 days ago - Bausch + Lomb to Hold Investor Day on Nov. 13 - Business Wire
- 6 days ago - Why Bausch Health Is A Buy After Rising 10% On Third-Quarter Results - Seeking Alpha
- 8 days ago - Bausch Health Companies Inc. (BHC) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Bausch Health Announces Third Quarter 2025 Results - Accesswire
- 17 days ago - Activist Investor Seeks Strategic Overhaul At Contact Lens Maker Cooper, Suggests Merger With Bausch + Lomb - Benzinga
- 4 weeks ago - Bausch Health Announces Results of Special Meeting of Shareholders - Accesswire
- 5 weeks ago - Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV - Accesswire